Your browser doesn't support javascript.
loading
Efficacy of the visual cognitive assessment test for mild cognitive impairment/mild dementia diagnosis: a meta-analysis.
Hsu, Jui-Hung; Liu, Chien-Cheng; Chen, I-Wen; Wu, Jheng-Yan; Huang, Po-Yu; Liu, Ting-Hui; Hung, Kuo-Chuan.
Afiliação
  • Hsu JH; Department of Anesthesiology, Chi Mei Medical Center, Liouying, Tainan, Taiwan.
  • Liu CC; Department of Anesthesiology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
  • Chen IW; Department of Nursing, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
  • Wu JY; School of Medicine, I-Shou University, Kaohsiung, Taiwan.
  • Huang PY; Department of Anesthesiology, Chi Mei Medical Center, Liouying, Tainan, Taiwan.
  • Liu TH; Department of Nutrition, Chi Mei Medical Center, Tainan, Taiwan.
  • Hung KC; Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
Front Public Health ; 11: 1293710, 2023.
Article em En | MEDLINE | ID: mdl-38026272
Background: Mild cognitive impairment (MCI) is an intermediate stage between normal ageing and dementia. The early identification of MCI is important for timely intervention. The visual cognitive assessment test (VCAT) is a brief language-neutral screening tool for detecting MCI/mild dementia. This meta-analysis evaluated the diagnostic efficacy of the VCAT for MCI/mild dementia. Methods: Medline, Embase, Google Scholar, and Cochrane Library were searched from their inception until August 2023 to identify studies using VCAT to diagnose MCI/mild dementia. The primary outcome was to assess the diagnostic accuracy of the VCAT for detecting MCI/mild dementia through area under the receiver operating characteristic curve (AU-ROC) analysis. The secondary outcome was to explore the correlation between VCAT scores and MCI/mild dementia presence by comparing scores among patients with and without MCI/mild dementia. Pooled sensitivity, specificity, and area under the curve (AUC) were calculated. Results: Five studies with 1,446 older adults (mean age 64-68.3 years) were included. The percentage of participants with MCI/mild dementia versus controls ranged from 16.5% to 87% across studies. All studies were conducted in Asian populations, mostly Chinese, in Singapore and Malaysia. The pooled sensitivity was 80% [95% confidence interval (CI) 68%-88%] and the specificity was 75% (95% CI 68%-80%). The AU-ROCC was 0.77 (95% CI 0.73-0.81). Patients with MCI/mild dementia had lower VCAT scores than the controls (mean difference -6.85 points, p < 0.00001). Conclusion: VCAT demonstrated acceptable diagnostic accuracy in distinguishing MCI/mild dementia in cognitively normal older adults. As a language-neutral and culturally unbiased tool, the VCAT shows promise in detecting MCI/mild dementia. Further studies in non-Asian populations are required. Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier: CRD42023453453.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Systematic_reviews Limite: Aged / Humans / Middle aged Idioma: En Revista: Front Public Health Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Taiwan País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Systematic_reviews Limite: Aged / Humans / Middle aged Idioma: En Revista: Front Public Health Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Taiwan País de publicação: Suíça